全球与靶向代谢组学识别急性主动脉夹层血清生物标志物
结果显示磷脂酰胆碱代谢通路显著改变,TMAO水平升高而肉碱、胆碱和甜菜碱降低,TMAO与疾病严重程度及炎症指标相关,可能作为AAD辅助诊断和评估的生物标志物。
要点
- AAD患者血清磷脂酰胆碱代谢通路显著改变,TMAO水平明显升高。
- TMAO与CRP、IL-6、D-二聚体及最大主动脉直径正相关。
- TMAO可能作为AAD辅助诊断和病情评估的潜在生物标志物。
核心结论
- AAD患者代谢物水平呈现以磷脂酰胆碱代谢通路为主的一致改变,TMAO可能作为辅助诊断和评估AAD的生物标志物。
主要发现
- 非靶向代谢组学显示AAD患者脂质和极性代谢物显著变化,靶向代谢组学进一步观察到磷脂酰胆碱代谢通路改变。
- AAD患者TMAO水平较对照明显升高(P < 0.005),肉碱(P < 0.005)、胆碱和甜菜碱(P < 0.05)水平降低。
- TMAO水平与AAD疾病严重程度相关,并与C反应蛋白(r = 0.537,P = 0.018)、IL-6(r = 0.546,P = 0.016)、D-二聚体(r = 0.694,P = 0.001)及入院时最大主动脉直径(r = 0.748,P = 0.002)呈正相关。
临床怎么用
- TMAO可能作为AAD辅助诊断和病情评估的血清标志物,但需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Acute aortic dissection (AAD) is the most devastating aortic pathology, and the incidence is increasing worldwide. However, the occurrence and development of AAD are unpredictable. A thorough understanding of the serum metabolic landscape through metabolomic analysis may help identify new biomarkers for AAD and offers new insights into its prevention and evaluation. METHODS: Nineteen patients with Stanford type A aortic dissection and 20 healthy individuals were enrolled in this study. We use global and targeted mass spectrometry-based metabolomics to investigate the serum metabolomics profiles, and the data were analyzed by principal component analysis and orthogonal partial least squares discriminant analysis. RESULTS: Initial untargeted metabolomics analysis revealed significant changes of lipids and polar metabolites in patients with AAD. Alterations of the phosphatidylcholine metabolic pathway were further observed by targeted metabolomics. Trimethylamine N-oxide (TMAO) levels were obviously increased in patients with AAD compared with controls (P < 0.005), whereas the levels of carnitine (P < 0.005), choline, and betaine (P < 0.05) were decreased. Furthermore, TMAO levels were associated with disease severity in AAD and correlated positively with C-reactive protein levels (r = 0.537, P = 0.018), IL-6 levels (r = 0.546, P = 0.016), D-dimer levels (r = 0.694, P = 0.001), and maximum aortic diameter on admission (r = 0.748, P = 0.002). CONCLUSIONS: Patients with AAD showed a predominant and consistent change of metabolites levels, especially the compounds in the phosphatidylcholine metabolic pathway. TMAO could potentially serve as a biomarker for the auxiliary diagnosis and evaluation of AAD.
引用
- Zeng Q, Rong Y, Li D, et al. Identification of Serum Biomarker in Acute Aortic Dissection by Global and Targeted Metabolomics. Ann Vasc Surg. 2020. PMID: 32599111. doi:10.1016/j.avsg.2020.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。